The current data confirm that ACS enhances circulating PTX3, but they further demonstrate that a negative impact of obesity on plasma PTX3 extends from non-ACS to ACS individuals. The gene discussed is PTX3; the disease is obesity due to melanocortin 4 receptor deficiency.